Clinical implementation of preemptive pharmacogenomics in psychiatry

This publication has 26 references indexed in Scilit:

• Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity
  The American Journal of Human Genetics, 2019
• Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
  Journal of Psychiatric Research, 2019
• The use of pharmacogenetic testing in patients with schizophrenia or bipolar disorder: A systematic review
  Mental Health Clinician, 2018
• Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility
  Journal of Psychiatric Research, 2018
• Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix®) to Guide Treatment of Patients with Depression and/or Anxiety
  PharmacoEconomics, 2017
• Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)
  European Journal of Clinical Pharmacology, 2017
• Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
  The Pharmacogenomics Journal, 2017
• Clinical Impact of Pharmacogenetic-Guided Treatment for Patients Exhibiting Neuropsychiatric Disorders
  The Primary Care Companion For CNS Disorders, 2017
• Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
  Clinical Pharmacology & Therapeutics, 2016
• Realities and Expectations of Pharmacogenomics and Personalized Medicine: Impact of Translating Genetic Knowledge into Clinical Practice
  Pharmacogenomics, 2010